1. No category

Lung Cancer and Head &
Neck Cancer Symposium
Saturday, March 28, 2015
Sheraton Overland Park, Overland Park, Kan.
Overview: Patients with stage III non-small cell lung cancer are a heterogeneous group that poses a
unique management challenge to the healthcare team. Treatment options vary, from aggressive triple
modality with chemoradiation followed by surgery for eligible patients to a less aggressive approach with
radiation or chemotherapy alone for patients who are not medically fit.
Careful consideration of patient characteristics and other health variables is imperative prior to making a
final decision about which treatment options to use. Input from a multidisciplinary team with a dedicated
thoracic surgeon, medical oncologist and radiation oncologist is extremely valuable to make the ideal
treatment recommendation. Innovative surgical techniques and radiation modalities have become
routine in the current management and incorporation of novel agents that are in development with the
chemoradiation approach.
The treatment of advanced head and neck cancer can lead to significant impairment of the aerodigestive
tract, causing debilitating dysphagia and dysphonia. Other long-term side effects, such as xerostomia
and dental decay along with hearing loss, are also common in long-term survivors. The appropriate
management of these long-term side effects early on, and the appropriate referral to a variety of specialists,
can help ameliorate the symptoms and improve the functional capacity of these patients.
This symposium will review recent developments in stage III lung cancer and head & neck cancer care.
Approved for a maximum of 4.25 AMA PRA Category 1 Credits™.
kumcce.ku.edu/head-neck-lung
Agenda
7:30 a.m. Registration, Exhibits and
Continental Breakfast
7:55 a.m. Welcome and Introductions
Chao H. Huang, M.D., FACP,
University of Kansas
8:00 a.m. Confronting the Medusa of
Thoracic Oncology
Chao H. Huang, M.D., FACP,
University of Kansas
8:30 a.m. Indications for Surgery in
Patients with Stage III Lung
Cancer
Nirmal Veeramachaneni,
M.D., University of Kansas
9:00 a.m. Novel Agents in
Development in the
Treatment of Stage III Lung
Cancer
Michael Kelley, M.D.,
Duke University
9:45 a.m. Refreshment Break and
Exhibits
10:00 a.m. Radiation Therapy
Considerations in the
Combined Modality in Stage
III Lung Cancer
Xinglei Shen, M.D.,
University of Kansas
10:30 a.m. Head & Neck Cancer
Treatment, Role of a MultiDisciplinary Supportive
Care Team
Prakash Neupane, M.D.,
University of Kansas
11:00 a.m. Dealing with Dysphagia: An
Ounce of Prevention
Jessica Barton, M.A., CCC-SLP,
B.C.S.-S., University of Kansas
11:30 a.m. Optimizing Nutrition in the
Head & Neck Cancer Patient
Laura Smith, RD, CSO, LD,
University of Kansas
Noon
Questions and Case Discussion
12:30 p.m. Closing Remarks and
Adjournment
Sponsored by the Division of Hematology & Medical Oncology and University of Kansas Medical Center
Lung Cancer and Head &
Neck Cancer Symposium
Saturday, March 28, 2015
Sheraton Overland Park, Overland Park, Kan.
Course Directors:
Chao H. Huang, M.D., FACP, Associate Professor, University of Kansas Medical Center, Kansas City, Kan.;
Staff Physician, Veterans Administration Medical Center, Kansas City, Mo.
Prakash Neupane, M.D., Assistant Professor, University of Kansas Medical Center, Kansas City, Kan.
Target Audience: This symposium is designed for physicians, nurses and healthcare professionals
specializing in head & neck and lung cancer.
Objectives: At completion of this symposium participants should be able to:
•
•
•
•
Recite key clinical trials ongoing for stage III disease.
Identify ideal patients for surgical resection in stage III lung cancer.
Recite the radiation techniques currently available for patients with stage III disease.
Identify and discuss the initial management of side effects related to chemoradiation in management of head
& neck cancer.
• Refer appropriate patients to specialists and co-manage severe adverse events related to long-term side effects
of head & neck cancer.
University of Kansas Medical Center is an AA/EO Title IX institution.
kumcce.ku.edu/head-neck-lung
The University of Kansas
Continuing Education
1515 St. Andrews Drive
Lawrence, KS 66047-1619
150582